Suchergebnisse - "Duyvesteyn, Helen M E"

PubPharm (7)

1

The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86

enthalten in: Nature communications | 2024

von Zhou, D. | Supasa, P. | Liu, C. | +14

2

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees

enthalten in: Cell | 2022

von Nutalai, R. | Zhou, D. | Tuekprakhon, A. | +33

3

Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2

enthalten in: Theranostics | 2022

von Huang, K. | Zhou, D. | Tan, T. | +26

4

Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant

enthalten in: Immunity | 2021

von Graham, C. | Seow, J. | Huettner, I. | +26

UpdateOf: bioRxiv. 2021 Feb 03;:. - PMID 33564766

5

The antigenic anatomy of SARS-CoV-2 receptor binding domain

enthalten in: Cell | 2021

von Dejnirattisai, W. | Zhou, D. | Ginn, H. | +50

6

Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient

enthalten in: Nature structural & molecular biology | 2020

von Zhou, D. | Duyvesteyn, H. | Chen, C. | +37

7

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

enthalten in: Nature structural & molecular biology | 2020

von Huo, J. | Le Bas, A. | Ruza, R. | +30

ErratumIn: Nat Struct Mol Biol. 2020 Nov;27(11):1094. - PMID 33060850

1
[1]